The International Society of Feline Medicine (ISFM), the veterinary division of International Cat Care, has announced the publication of the new ISFM Consensus Guidelines on the Diagnosis and Management of Feline Chronic Kidney Disease in this month's Journal of Feline Medicine and Surgery1.
The guidelines represent the consensus of an expert panel of clinicians and academics gathered from the UK, France, Australia and North America. In making their recommendations, the panelists considered various management approaches and graded the quality of the available published evidence with respect to their impact on quality of life and longevity.
The authors say dietary management is supported by good evidence. Notably, specific commercial renal diets have been shown to significantly prolong longevity and improve quality of life. A common problem, however, is poor acceptance of these diets, which are generally less palatable than maintenance diets, and the guidelines include a number of recommendations to assist in transitioning cats to a new diet.
Other interventions with good supportive evidence are routine assessment of blood pressure in cats with CKD, and use of antihypertensive medications (when indicated) to help protect organs at particular risk of damage, such as the eyes and heart.
Given the chronic nature of CKD, the guidelines, which are free to access and download, emphasise how vital it is for the veterinary clinic to establish a good relationship with the cat’s owner. This will facilitate treatment plans to be created that take into consideration the wishes and ability of the owner, as well as the needs of the individual cat.
You can read the guidelines here. There is also a podcast recording of the panel chairman Dr Andrew Sparkes discussing the guidelines is available here.
Reference
Pfizer Animal Health is advising vets and horse owners to be on guard against the threat of West Nile Virus (WNV) in the UK, following a spate of outbreaks of the disease in several European countries this year.
West Nile Virus has recently made headline news because of a human outbreak in Greece which resulted in a number of deaths. Outbreaks have also occurred in Russia, Romania and Italy during 2010. West Nile Fever is a viral disease transmitted by mosquitoes, which carry the virus after biting infected birds. Primarily occurring between July and October, in line with typical peak activity of mosquitoes, it can have serious consequences on human and equine health, with severe cases resulting in fatal neurological disease.
There is no cure, though supportive treatment can aid recovery. However if the disease progresses to a state where the animal is not able to stand up, their chance of survival is considered low. Prevention of infection is difficult, but any steps that reduce mosquito numbers or the likelihood of horses and people being bitten may help to reduce the risk in areas where the disease is present. However, the only way to reduce the risk of an individual horse developing disease due to WNV is through vaccination.
Ben Gaskell, Pfizer's equine veterinary advisor said: "West Nile Virus may well become a very real threat to both horses and humans in Northern Europe. It is important for vets, horse owners and infectious disease experts to work together to mitigate its impact in the event of the virus becoming endemic across Europe. The rapid spread of the disease across North America is an illustration of what could potentially happen in Europe and it is important to remember there is no curative treatment - the only way to prevent clinical disease in horses is by vaccination."
Pfizer Animal Health supports the PrEquID (Prevention of Equine Infectious Disease) group, which consists of internationally recognised equine and infectious disease experts. The group was formed to develop guidelines on the prevention and control of a number of equine infectious diseases, on a global basis.
Klaus Osterrieder, Professor and Chair in the Institut für Virologie in the Veterinärfakultät at Freie Universität Berlin, Germany and a member of the PrEquID group advises: "Horse owners should ask their veterinarian for advice on appropriate prevention measures. Experience has shown that adopting a prudent prevention strategy can be a very effective way of managing this devastating disease."
Further information on WNV is available at www.westnile.eu.
The University of Bristol and Companion Care have launched The Great Pet Travel Survey 2012 to assess disease risks in the UK following the simplification of Pet Travel Scheme rules.
Companion Care and The University of Bristol say that there is a great deal of concern about what risks changes in the Pet Travel Scheme Rules pose to the health of the human and dog population in the UK.
Robert White-Adams MRCVS from Companion Care said: "At present there is minimal data available to answer this question as current data logging is minimal and paperwork checking at ports can be variable. We therefore have little idea of how many UK-resident dogs travel abroad, where they visit, how long they stay and what they are doing whilst abroad.
The survey will collect and analyse information about the travel patterns of UK resident dogs, in and around mainland Europe, over the last decade.
Robert added: "The data to be collated by the survey will fill the data void and enable us to provide a quantitative assessment of the disease risk, as well as gaining an understanding of owner awareness of risks face by dogs travelling in Europe.
Owners of dogs with Pet Passports are being encouraged to fill in the short questionnaire, which is available now at http://www.greatpetsurvey.co.uk/. All completed questionnaires will be entered into a prize draw to win £100 of Pets at Home vouchers!
The questionnaire will be live online until 30th June 2012 and all data will be analysed by the University of Bristol.
Dr Morgan said: "Without this information we have only a vague idea of the risks that the loss of border controls may pose. The answer could be that there is little additional risk or it could be that the UK dog (and human) population could face some severe disease threats. As it stands now, we just don't know enough to make an informed judgement."
The Kennel Club Genetics Centre at the AHT has identified a genetic mutation which causes a severe progressive disease in Parson Russell Terriers (PRTs).
Late onset ataxia (LOA) affects coordination and balance, making everyday movement and tasks increasingly difficult. The new DNA test can accurately predict the risk of developing the disease in 97-100 per cent of PRTs and will effectively reduce the number of LOA cases in the breed.
Dogs usually develop the disease between six months and one year of age but because there is no cure, sufferers are usually euthanised around two years after onset as their quality of life diminishes.
After testing DNA of over 200 PRTs in total, the AHT's scientists were able to isolate the genetic mutation which causes the disease and establish that LOA is an inherited recessive trait; therefore dogs must have two defective copies of the genetic mutation, one from each parent, to be affected.
The test results will inform dog owners if their dog is clear from, a carrier of, or affected by LOA.
Cathryn Mellersh, Head of Canine Genetics, at the AHT said: "This is great news for PRT breeders as we believe LOA is an emerging condition in the breed and through this test we should be able to cut the disorder 'off at the pass', before the mutation becomes any more widespread.
"Interestingly, our research also suggests that there may be other causes of ataxia in the breed. It is important for breeders to understand that a clear result using the LOA DNA test will not exclude the formal possibility that dogs could still develop a genetically different form of ataxia."
Caroline Kisko, Kennel Club Secretary, said: "LOA is a relatively new but devastating condition and we are delighted that we've been able to work with the Animal Health Trust to develop a DNA test that will give breeders the opportunity to significantly reduce this disease. We will keep working together to develop tools and information for breeders, so that they are able to select dogs that will have healthy puppies."
The DNA test for LOA is available from the AHT at the price of £48. Full details are available at www.ahtdnatesting.co.uk.
Oxyglobin, Dechra’s unique haemoglobin-based oxygen carrying fluid for the treatment of anaemia in dogs, is now readily available in the UK.
“Over the past year, demand for this leading product has outstripped our limited supply from the manufacturer Biopure®,” explains Carol Morgan, product manager at Dechra Veterinary Products. “Production and supply issues in the US have now been resolved which means we can assure the future supply of Oxyglobin via the wholesaler to practices.”
Dechra is the sole distributor of Oxyglobin in the UK. The product requires no typing or cross matching and ensures no transfusion reactions or disease transmissions. “Its effectiveness can be measured by a rapid improvement in clinical signs, increased plasma haemoglobin concentration and arterial oxygen content. Oxyglobin has certainly proved itself as a valuable product to have in any practice,” adds Carol Morgan.
Oxyglobin can be stored at room temperature and has a shelf life of three years. For further details, please contact your local territory manager or phone Dechra on 01743 441 632.
Dechra Veterinary Products, manufacturer and distributor of Equipalazone®, has launched a new information leaflet to support the Equine Passport scheme.
Since 2005, when equine passports became mandatory, 958,000 have been issued. The passport is a method of identification as well as a medical record and ensures that horses treated with veterinary medicines do not enter the human food chain.
“Many substances used in commonly prescribed equine medicines can only be given to horses not intended for human consumption,” says Giles Coley, Dechra’s managing director. “Under the passport scheme, owners must declare whether their horse is intended for human consumption.
The leaflet, which outlines the importance and benefits of the Equine Passport scheme, will be inserted into every box of Equipalazone Powder 100 sachets. It will also be made available for veterinary practices to hand out to their clients.
Practices wishing or order copies of the Equine Passport leaflet should contact Rachel Horton at Dechra on 01743 441 632.
Intervet/Schering-Plough Animal Health, has launched a new guide entitled ‘Your guide to Exotic Diseases', to educate horse owners on these potentially fatal, insect-borne diseases, some of which are zoonotic.
Joining the company's guides on respiratory disease and vaccination, the leaflet features information on West Nile Virus, African Horse Sickness, Equine Infectious Anaemia (Swamp Fever) and Equine Encephalitis including overviews of each of the diseases and their clinical signs.
Spread by a variety of insect-borne vectors including midges, mosquitoes and horseflies, climate change is increasing the risk of exotic diseases having a severe impact on the country's equine industry. What's more, African Horse Sickness is transmitted from animal to animal by infected biting Culicoides midges, the same midges that carry the Bluetongue virus which has threatened UK livestock this year.
"It's essential that horse owners are aware of the threat of exotic diseases coming in from overseas and the clinical signs to look out for, especially during the summer and autumn months when diseases transmitted by insects are more likely to appear." comments Tim Zoch, Marketing Manager at Intervet/Schering-Plough Animal Health. "Our new leaflet features easy-to-understand overviews of each of the diseases to help educate owners, and practices can expect strong demand from their clients"
For further information about Intervet/Schering-Plough's range of horse owner guides, including ‘Your guide to Exotic Diseases', please contact your Intervet/Schering-Plough Account Manager or call the Veterinary Support Group on 01908 685685.
A European study undertaken in horses to evaluate the efficacy of the key anthelmintic molecules fenbendazole, pyrantel, ivermectin and moxidectin in treating equine cyathostomins, has confirmed that resistance is developing against all the molecules with the exception of moxidectin.
Resistance to fenbendazole was highlighted as a particular issue with 80% of the yards tested in the UK and Germany showing resistance. Resistance to pyrantel also proved to be increasingly prevalent while cases of ivermectin resistance were emerging.
The Fort Dodge-sponsored study, the largest of its kind so far undertaken, took place during 2008 and was led by scientific teams from veterinary faculties in Italy and Germany. It was based on Faecal Egg Count Reduction Tests (FECRTs) of 1,704 horses at 102 yards in Italy, Germany and the UK. The calculation of FECR data was performed employing bootstrap analysis of group arithmetic means.
The study concluded that:
According to Dr Donato Traversa from the University of Teramo, Italy, who headed up the field work, the results confirm that single and even multiple drug resistance in equine cyathostomins is an increasing challenge in all three countries with resistance to fenbendazole and pyrantel a particular concern.
He said: "Our research highlights the necessity for vets, owners and managers to use those anthelmintic molecules that remain most effective in a manner which preserves their efficacy for as long as possible."
Professor Georg von Samson Himmelstjerna from Hannover University of Veterinary Medicine, which participated in the research, added: "Given the strong impact that resistant cyathostomins are likely to have on horse welfare, future parasite control plans should be based on integrated measures, involving both the correct use of anthelmintics, such as administering the correct dosing according to the animals weight, and only using products in the species for which it is licensed, as well as other approaches such as adequate pasture hygiene, low stocking rates and mixed grazing with other animals.
"We call on all concerned with equine health and welfare to take an active role in planning and monitoring effective worm control programs."
The interactive module, which lasts around 30 minutes, is presented by leading cardiologist Clarke Atkins, professor of medicine and cardiology at North Carolina State University.
A CPD certificate can be downloaded after completing a quiz at the end of the module.
To access the Cardio Academy visit http://www.cardioacademy.cevalearn.com/.
The survey - Surveillance use, understanding and engagement across the veterinary profession - is being carried out by the BVA's Surveillance Working Group, which is made up of 12 members of BVA and its divisions who have expertise in veterinary surveillance.
Chair of the BVA Surveillance Working Group, Kate Sharpe, said: "Following several reviews, the surveillance landscape has changed in England and Wales. This survey is your chance to tell us how you engage with the current system, what you value about the surveillance reports produced and to identify areas for improvement. We want to hear from the full breadth of the profession.
"Whilst we know that disease surveillance is a priority for the profession we would like to understand what drives veterinary professionals to engage with the scanning surveillance system as it currently stands and the barriers which prevent or limit engagement.
"This increased understanding will enable BVA to clearly set out its position on current surveillance systems and highlight key questions to pose to the Government in order to improve surveillance delivery, especially as we head into Brexit negotiations."
The survey was drafted by members of the Surveillance Working Group, with representatives from BVA’s specialist divisions, and will be promoted to members of all relevant veterinary associations.
It is the first of a series of surveillance surveys that will also include localised surveys for Northern Ireland and Scotland. Data collected will inform BVA’s policy position ensuring it is representative of disease surveillance across all the UK.
The survey will run until Friday 31 August 2017 and the BVA says that depending on your area of work, will take no longer than 20 minutes to complete. As a thank you, participants will also be entered into a prize draw to win a £100 Amazon Voucher.
Take the survey.
The new gel is made from natural resin combined with zinc salts which NoBACZ says provides both physical and microbial protection.
NoBACZ says that unlike water-based gels and sprays, including aerosols, that dilute in water and wash away, Ambugreen’s natural resin is hydrophobic which improves contact times between the product and the skin in wet conditions.
The gel barrier can be used anywhere on the skin where a bandage or spray has conventionally been used for protection, such as the management of lameness and to protect sore skin in livestock and to manage udder cleft issues in cows.
Ambugreen also offers fly protection and is suitable for use on all livestock, including copper-sensitive sheep breeds.
Dr David Charles, veterinary surgeon and international business development manager at NoBACZ Healthcare, said: “Ambugreen provides farmers with next generation protection for their livestock and is the perfect antibiotic-free tool to help protect wounds from bacterial ingress from the environment; enhancing the health and welfare of animals whilst preventing economic losses.”
Laura Donovan, veterinary surgeon and partner at Nantwich Farm Vets, adds: “We were lucky enough to have trialled Ambugreen with our dairy clients who have successfully used the gel barrier for udder cleft dermatitis and were very pleased with the results.”
www.nobacz.com
VRCC veterinary referral centre, the leading European veterinary cancer treatment centre, has announced that it has installed what is believed to be the first and only new 'Human' CT scanner in a UK private small animal veterinary centre, at a cost of nearly £500,000. The announcement came less than a year after the centre's 6 million volt linear accelerator went online - currently the only veterinary radiotherapy facility in the UK. Apart from routine scans required by all the clinicians at the centre, VRCC also takes referrals in medicine, surgery and oncology. Its CT will also be used in conjunction with the linear accelerator, offering sophisticated cancer treatments previously not available in the UK. In another first for VRCC, the centre has appointed Tom Jackson BSc Radiography (T), a therapeutic radiographer from Guys & St Thomas Westminster, a centre of excellence in oncology. Tom will be working under the direction of the centre's clinical director, Dr Susan North, the most highly qualified and experienced veterinary oncologist in the UK and the only qualified radiation veterinary oncologist in the UK.
For more information about the referral services available from VRCC, visit http://www.vrcc.co.uk/, or ring 01268 564664.
The Federation of European Companion Animal Veterinary Associations (FECAVA) has launched the European Journal of Companion Animal Practitioners (EJCAP) Online, the first European fully online veterinary journal.
As the official journal of the FECAVA, the EJCAP online is exclusively available to members of national companion animal veterinary associations which are in turn members of FECAVA (which include the BSAVA).
According to FECAVA, the EJCAP online will continue to offer the sort of high quality CPD articles which the magazine was known for during its 21 year history in print. However it will now also be able to offer rich media, such as videos with clinical presentations, endoscopy and ultrasound recordings, diagnostic and surgical techniques, interviews with experts, conference presentations as well as slide shows, interactive quizzes, surveys and animations.
The frequency of publication has also been increased, from three to four issues per year, including one special issue.
The EJCAP online is available in two languages - English and Spanish. More languages are planned in future.
Simon Orr, FECAVA president, said: "Since the momentous decision to publish EJCAP online was taken by our Council in Lille in 2009, we are delighted to offer our members this new and engaging way to gain new information and skills.
As we start work on the next issues, we invite all our readers to give us feedback on this first volume of EJCAP online. On the last spread (page) there is a link to a survey on this new format, to help us further improve and optimize EJCAP online."
To register, visit EJCAP online (www.fecava.org/ejcap).
Guidance for veterinary surgeons and veterinary nurses on client confidentiality and microchipping has been amended by the RCVS.
The amendments deal with situations when a client presents an animal registered in another person's name, and a new flow diagram has been added to provide additional practical advice for vets and VNs dealing with these types of situations.
Animals can be registered in a different name to that of the client for various reasons. For example, an animal may have been re-homed or sold, but the details on its microchip have not been updated; it could have been stolen; or, the owners may be involved in a civil dispute.
Veterinary surgeons in practice may be unsure what to do in these situations. The new guidance informs veterinary surgeons about their options and provides advice on client confidentiality and data protection issues.
The College advises that veterinary nurses employed by a veterinary surgeon or practice should discuss the issues with a senior veterinary surgeon in the practice before breaching client confidentiality.
The amendments apply to Chapter 14 of the supporting guidance to the RCVS Code of Professional Conduct. The supporting guidance and flow diagram are available at: www.rcvs.org.uk/confidentiality.
The original deadline for nominations for the three honours (the Queen’s Medal, Golden Jubilee Award and Honorary Associateship) was Friday 16 September – this has now been moved to Friday 21 October 2016.
Chris Tufnell, President of the RCVS, said: "Do you know someone who goes above-and-beyond the call of duty? Whose achievements have had a tangible impact on their profession or the veterinary and animal health and welfare sector at large? Then we would strongly encourage you to nominate them for an RCVS Honour. Those who are successful will receive their award at our Annual General Meeting and Awards Day where their achievements will be described and recognised in front of their peers."
The Queen’s Medal was introduced in 2013 and is the highest honour that the College can bestow upon a veterinary surgeon in recognition of those who have achieved a highly distinguished career and outstanding achievements. Nominations can be made by any Member of the RCVS in respect of another veterinary surgeon.
The Golden Jubilee Award was introduced in 2011 to mark the 50th anniversary of the first RCVS training course for veterinary nurses and now recognises those nurses who are taking a leadership role within the profession. Nominations can be made by either veterinary nurses or veterinary surgeons in respect of a veterinary nurse.
Finally, nominations can also be made for Honorary Associateship which is eligible for those who, while not veterinary surgeons or nurses, have had a significant impact in the veterinary field. Previous winners have included scientists, farmers, farriers, educationalists and journalists.
Further information about making nominations for each of these awards, including nominations forms, can be found at www.rcvs.org.uk/honours. All awards will be bestowed at RCVS Day 2017 in July next year.
Those with questions about making a nomination can contact Peris Dean, Executive Secretary, on p.dean@rcvs.org.uk
The project was launched as a joint initiative between the RCVS and the BVNA in 2016. Its objectives included highlighting veterinary nursing as a career, encouraging more people into veterinary nursing, improving retention, expanding the scope of the VN role, and providing more opportunity for career progression.
The report begins by highlighting perhaps the biggest challenge facing the profession, that in 2019, 25% of veterinary nurses said they plan to leave the profession in the next five years, largely because of poor pay, because they don't feel sufficiently valued, lack of career opportunities and because of a poor work/life balance.
The main achievements of the project, which should certainly help with some of these issues, include:
Jill Macdonald, VN Futures Project Coordinator, said: "The report is a culmination of years of hard work, putting in place measures to champion the veterinary nursing profession and safeguard it for the future. Through the introduction of initiatives like the School Ambassador Development Programme and the introduction of the CertAVN, to name but a few, we have put in place steps to inspire the next generation of veterinary nurses and support the training and development of people currently working in the profession."
You can read the full VN Futures Interim Report at https://www.vnfutures.org.uk/resource-items/vn-futures-interim-report-2021
Vets, consultants and other advisors should encourage dairy farmers to make use of available information to help improve their herd's performance and profitability through breeding. This is the message from DairyCo breeding+ director, Marco Winters, who says farmers should use genetics to improve not only milk production, but also health, welfare, management and type traits.
Breeding briefs, a new booklet from DairyCo, identifies some genetic improvement tools that allow farmers to make better breeding decisions and concentrates on how to use them in practice. And for those who feel confronted by an overload of information, the booklet helps identify the figures to seek out and prioritise.
Breeding decisions are cumulative: their effects build up over the generations so a problem can be introduced or cured over just a few years. A series of poor breeding decisions can mean the difference between profit and loss; even between a business's survival and failure. Yet the time, cost and effort needed for a good breeding decision to be made is much the same as those needed for a bad one.
Mr Winters says: "High quality cattle are at the heart of profitable dairy farming and this requires good quality genetics. Without these, however good farmers' management, there is a ceiling to their herd's performance and profitability. Vets, consultants and other dairy advisers have an important role to play in helping farmers access the information they need to make informed decisions."
DairyCo Breeding briefs is available to download from http://www.dairyco.org.uk/. To request a pdf version by email call 01285 646510 or email: publications@dairyco.org.uk.
Pfizer has sponsored the publication of a new English-Polish dairy health guide for vets to give farmers.
The guide has been published to help farm staff from Poland improves their knowledge, skills and performance at work. Topics covered including milking routines, causes and control of clinical mastitis, intramammary tube infusion and dry cow therapy.
Copies are available free of charge from Pfizer Animal Health's Dairy Territory Managers, or by calling 01737 330727.
A survey of more than 3,000 farms has found that 16% employed foreign workers, among whom more than half were from Poland.1 According to Pfizer's livestock business director Tomas Rosival, Polish workers are keen on training and eager to put it into practice and get results.
He said: "Communication is the key. By presenting each topic in English and Polish on facing pages, the booklet helps develop workplace vocabulary and language skills as well as improving technical knowledge."
[1] Farm Business, 2009. The significance of migrant labour in UK agricultural employment. Survey of 3,375 farms.
Diverse Undertakings Ltd. has announced that it is extending its services to include support for veterinary practices in securing their RCVS Practice Standards Scheme (PSS) accreditation.
The company was originally formed to provide business advisory services to small and medium sized enterprises across a range of industry sectors. Its services range from general H.R. advice, health & safety guidance and facilities management to candidate sourcing and call-centre services.
However, with previous experience supporting a substantial veterinary practice in Kent for both employment challenges and PSS accreditation, Company Director Neal Palk decided to extend the company's capability to support other veterinary practices in securing their PSS accreditation.
He says that because the needs of each practice vary, Diverse can adapt its service to reflect both the individual circumstances relating to accreditation as well as the capability/capacity with the practice to undertake necessary tasks itself. By using a network of associates, he says Diverse can call upon other specialities (for example - competitively priced office/building equipment) to smooth the progress to accreditation.
Diverse says it offers a range of transparent pricing options to suit the client which, without the overheads of large consultancies, often result in PSS accreditation being achieved for less cost than a typical administrative temp for a month. Monthly retention fee alternatives for other services are available, beginning at £95+ VAT.
Neal said: "Several organisations offer professional services to the veterinary practice sector, but few can claim to have 'been there, done that' and really understand the climate and culture the sector operates within. Diverse Undertakings Ltd. values its experience in the sector and aims to work with other practices to achieve both accreditation and wider business success."
For more details please contact Neal on 07771 843719, e-mail: info@diverseundertakings.com, or visit: http://www/diverseundertakings.com
The RCVS has restored its full approval to the University of Bristol's School of Veterinary Science.
The full approval was granted by the RCVS Council in March, at the recommendation of the Education Policy and Specialisation Committee (EPSC), following the positive report of a visitation carried out in mid-December 2011 under the chairmanship of former RCVS President Stephen Ware.
The School had been under conditional approval since a visit in March 2007, and a subsequent revisit in October 2009 had identified that although progress had been made, work still needed to be completed to improve some of the facilities, particularly in small animal surgery and on the farm.
The RCVS Council commended the hard work and improvements displayed by the School, and was pleased to restore it to full approval status.
Professor Stuart Reid, EPSC Chairman said: "The University has demonstrated a welcome and continued commitment to the development of the School, and is to be congratulated on making significant financial investments in staffing and facilities, despite the current difficult economic climate.
"There is a positive and constructive atmosphere, which is a credit to the Head of School and all the staff who have clearly worked extremely hard to meet the challenges presented to them at a time of change within the university sector as a whole."
The School is next scheduled for a full visitation in 2014.
Ceva Animal Health has produced a leaflet to help horse owners understand the cause, diagnosis and management of equine back pain.
The company says the management of back pain in the horse can be a particular challenge to vets and a source of frustration for owners. Early diagnosis is likely to be associated with a more favourable outcome but it's important to ensure that other causes of pain and poor performance such as lameness, are not contributing to the horse's clinical signs.
'Understanding back pain' explains the anatomy of the back, as well as the clinical signs of back pain, and how it is diagnosed, including the treatment options and the general prognosis. Copies of the new leaflet are available, free of charge, from your Ceva sales representative. Leaflets on 'Understanding bone spavin', 'Understanding navicular disease', 'Understanding sacroiliac disease' and 'Equidronate discharge instructions', are also available.
For further information contact your local Ceva representative or Ceva Animal Health Ltd, Unit 3, Anglo Office Park, White Lion Road, Amersham, Bucks, HP7 9FB, Telephone +44 (0) 1494 781510.
Once again, there are awards for both individual receptionists and reception teams
The winners will receive trophies and Amazon vouchers.
Emma Coole, Account Manager for the South West of the UK at KRKA UK said: "Reception teams are the glue that holds a busy practice together.
"They’re juggling phone calls, managing appointments, supporting worried pet owners at the front desk - and doing it all with empathy and professionalism.
"I regularly see and hear first-hand how much the wider vet practice depends on their calm, capable presence.
"These awards are a chance to recognise the people who make that happen every single day.”
Practices are encouraged to nominate receptionists or teams who make a real difference – whether through kindness, a cool head under pressure or simply keeping everything running smoothly.
Nominations are now open and will close on Friday 26th September 2025.
Winners and runners-up will be announced on Wednesday 1st October 2025.
To submit a nomination or learn more about the awards, visit https://bit.ly/receptionist-team-hero-awards-2025
kcs-intervet.swfIntervet / Schering-Plough Animal Health is running a challenge over the next few months to encourage the early diagnosis of Keratoconjunctivitis sicca (KCS), a painful disease which leads to permanent blindness (see right).
Practices are being asked to perform a Schirmer Tear Test (STT) on 50 dogs not previously diagnosed with KCS for the chance to win one of 70 Samsung digital cameras.
Recent studies¹ have shown the incidence of KCS to be 4.6% of the UK dog population, rising to 8.3% in predisposed breeds. However, 20 veterinary practices have recently participated in an Early Diagnosis Programme and the number confirmed with KCS was 9.7%². 17 of the cases diagnosed had Schirmer Tear Test readings of zero.
KCS is thought to be under-diagnosed because not all cases have the classic 'textbook' appearance but look surprisingly normal despite severely reduced tear production. In addition, diagnosis usually requires clinical suspicion and a Schirmer Tear Test.
Claudia Hartley, BVSc CertVOphthal DipECVO MRCVS, European Specialist in Veterinary Ophthalmology believes that: "All sore eyes (except where a descemetocoele is present) should have a Schirmer Tear Test, whether or not there is corneal change."
Melanie Dass MA VetMB CertSAM MRCVS ACIM, Product Manager for Optimmune said: "The results of our Early Diagnosis Programme made interesting reading and supported what we have always suspected - that KCS is under-diagnosed. It's really important that dogs suffering from this disease are detected promptly as early diagnosis and treatment with Optimmune gives the best prognosis.
"As part of the Early Diagnosis Programme owners of predisposed breeds received a personalised mailing offering them a free Schirmer Tear Test and some practices also elected to test all breeds at routine consultations such as vaccination. The tests were generally performed by veterinary nurses after they had received training, with the diagnosis made by a veterinary surgeon."
For more information about KCS, Optimmune and support in implementing an Early Diagnosis Programme, please contact your local Intervet / Schering-Plough Animal Health Territory Manager or call 01908 685685.
References¹ Pierce V & Williams D, 2006. Determination of Schirmer Tear Tests values in 1000 dogs. BSAVA Abstract 2006.² Intervet / Schering-Plough Animal Health Practices Study 2009
The taskforce was established following the EU referendum result on 24 June, with the central purpose of putting the profession in charge of its future by maximising the opportunities and minimising the risks of Brexit.
Almost half of veterinary surgeons registering in the UK qualified from veterinary schools elsewhere in the EU. While the Government issued a statement in mid-July clarifying that as yet there has been no change to the rights and status of EU nationals in the UK or UK nationals in the EU, it is not clear whether this situation will continue once the UK has left the EU.
The Brexit Presidential Taskforce will consider, and proactively engage with, the many possible changes that could shape the future of the UK veterinary profession due to Brexit.
The members of the Taskforce are: the President of the College, Chris Tufnell; the CEO, Nick Stace; the Treasurer, Amanda Boag; Operations Director, Corrie McCann; Junior Vice-President, Stephen May; Acting Registrar, Eleanor Ferguson; Chair of Education, Susan Dawson; Head of Education, Chris Warman; Council member Stuart Reid; Chair of VN Council, Liz Cox; and Director of Strategic Communications, Lizzie Lockett.
The terms of reference include: considering how EU regulations currently impact the regulation of veterinary professionals in the UK, and making recommendations as to which should be maintained; looking at the issue of mutual recognition of veterinary graduates in Europe; considering workforce requirements and the implications of a new system of immigration; understanding the implications for the current RCVS agenda; considering whether a proactive RCVS agenda can influence any new UK legislation; reconsidering the College’s existing international strategy; and studying the financial impact on the College.
It was also agreed that the College should maintain communications with the British Veterinary Association and coordinate approaches where appropriate.
Dr Chris Tufnell, President of the RCVS, said: "Brexit has profound implications for our professions. The Presidential Taskforce is exploring all implications and will develop proposals that will seek to mitigate the risks and maximise the benefits that can flow to the veterinary professions and to animal welfare.
"We are working closely with representative bodies and others so that the veterinary professions have a coordinated and well executed plan in place. We are in discussions with all relevant Government departments, working collaboratively and constructively, ensuring that our voice is heard and our influence is felt."
The next meeting will be held on 15 September, with the third one scheduled for 9 November.